Calreticulin couples with immune checkpoints in pancreatic cancer

Although immune checkpoint blockade is considered to be the dominant approach in future cancer immunotherapy, whether it will apply to pancreatic cancer remains largely unknown. To address this issue, pancreatic cancer–associated datasets were individually collected by Gene Expression Profiling Inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xing, Tang, Tianyu, Wang, Xun, Bai, Xueli, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239268/
https://www.ncbi.nlm.nih.gov/pubmed/32508042
http://dx.doi.org/10.1002/ctm2.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239268/
https://www.ncbi.nlm.nih.gov/pubmed/32508042
http://dx.doi.org/10.1002/ctm2.10

Ejemplares similares